These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 6201140
1. Tyrosinase activity and abundance in Cloudman melanoma cells. Halaban R, Pomerantz SH, Marshall S, Lerner AB. Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140 [Abstract] [Full Text] [Related]
2. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle. Abdel-Malek ZA, Swope VB, Trinkle LS, Nordlund JJ. Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505 [Abstract] [Full Text] [Related]
3. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures. Fuller BB, Lunsford JB, Iman DS. J Biol Chem; 1987 Mar 25; 262(9):4024-33. PubMed ID: 3031058 [Abstract] [Full Text] [Related]
4. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP. Hoganson GE, Ledwitz-Rigby F, Davidson RL, Fuller BB. Somat Cell Mol Genet; 1989 May 25; 15(3):255-63. PubMed ID: 2543086 [Abstract] [Full Text] [Related]
5. Regulation of tyrosinase in human melanocytes grown in culture. Halaban R, Pomerantz SH, Marshall S, Lambert DT, Lerner AB. J Cell Biol; 1983 Aug 25; 97(2):480-8. PubMed ID: 6411733 [Abstract] [Full Text] [Related]
6. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins. Abdel Malek ZA, Kreutzfeld KL, Marwan MM, Hadley ME, Hruby VJ, Wilkes BC. Cancer Res; 1985 Oct 25; 45(10):4735-40. PubMed ID: 2992767 [Abstract] [Full Text] [Related]
11. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density. Fuller BB, Lebowitz J. J Cell Physiol; 1980 May 25; 103(2):279-87. PubMed ID: 6254996 [Abstract] [Full Text] [Related]
13. Upregulation of mRNA for the melanocortin-1 receptor but not for melanogenic proteins in macrophage x melanoma fusion hybrids exhibiting increased melanogenic and metastatic potential. Chakraborty AK, Funasaka Y, Ichihashi M, Sodi S, Bhattacharya M, Pawelek J. Pigment Cell Res; 1999 Dec 25; 12(6):355-66. PubMed ID: 10614575 [Abstract] [Full Text] [Related]
14. Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone. Jiménez M, Kameyama K, Maloy WL, Tomita Y, Hearing VJ. Proc Natl Acad Sci U S A; 1988 Jun 25; 85(11):3830-4. PubMed ID: 3131764 [Abstract] [Full Text] [Related]
15. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma. Thody AJ, Oliver I, Sherbet GV. Eur J Cancer Clin Oncol; 1988 Dec 25; 24(12):1879-84. PubMed ID: 2851444 [Abstract] [Full Text] [Related]
16. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro. Lee TH, Lee MS. Acta Endocrinol (Copenh); 1977 Mar 25; 84(3):663-72. PubMed ID: 402759 [Abstract] [Full Text] [Related]
17. Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells. Wong G, Pawelek J. Nature; 1975 Jun 19; 255(5510):644-6. PubMed ID: 806022 [No Abstract] [Full Text] [Related]
18. Endocrine responsiveness in human melanocytes and melanoma cells in culture. Fuller BB, Meyskens FL. J Natl Cancer Inst; 1981 May 19; 66(5):799-802. PubMed ID: 6262556 [Abstract] [Full Text] [Related]